Abivax Adr (ABVX)

Nov 19, 2024

Abivax Initiates $150 Million ATM Program on Nasdaq - TipRanks

Nov 19, 2024

Nov 14, 2024

Abivax Reports Strong Q3 Financials and Clinical Progress - TipRanks

Nov 14, 2024

Oct 15, 2024

Check Out Abivax ADR (ABVX)’s Trade Data Rather Than the Analysts’ Views - SETE News

Oct 15, 2024

Oct 15, 2024

Insider’s View: Deciphering Abivax ADR (ABVX)’s Financial Health Through Ratios - The Dwinnex

Oct 15, 2024

Oct 07, 2024

Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation - GlobeNewswire Inc.

Oct 07, 2024

Sep 26, 2024

Abivax SA Unveils New Ulcerative Colitis Treatment Data - TipRanks

Sep 26, 2024

Sep 25, 2024

Abivax Reports Progress in Ulcerative Colitis Therapy - TipRanks

Sep 25, 2024

Sep 16, 2024

DEADLINE ALERT for ABR, FIVE, DXC, and INDV: The Law - GlobeNewswire

Sep 16, 2024

Sep 14, 2024

Wall Street Analysts Believe Abivax SA Sponsored ADR (ABVX) Could Rally 193.62%: Here's is How to Trade - MSN

Sep 14, 2024

Sep 13, 2024

Is Abivax SA Sponsored ADR (ABVX) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Sep 13, 2024

Sep 09, 2024

Abivax SA Details Financial Struggles and Advances - TipRanks

Sep 09, 2024

Sep 09, 2024

Abivax SA Reveals Soaring R&D Costs in H1 2024 - TipRanks

Sep 09, 2024

Jul 15, 2024

Inflammatory Bowel Disease Treatment Market Size Expected to Reach USD 33.19 Bn by 2032 - GlobeNewswire Inc.

Jul 15, 2024

Jun 04, 2024

Abivax SA Advances with Positive Trial OutcomesTipRanks.com - TipRanks

Jun 04, 2024

Apr 11, 2024

Abivax ADR receives Investment Bank Analyst Rating Update By Investing.com - Investing.com

Apr 11, 2024

Apr 02, 2024

Abivax SA Secures Funding and Expands Operations - TipRanks

Apr 02, 2024